Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    CLOMIPRAMINE HYDROCHLORIDE [EP MONOGRAPH]

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 384Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    31/10/2025 Biophore India Pharmaceuticals Pvt Ltd
    India
    		 BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad IN R0-CEP 2017-288 - Rev 01 Clomipramine Hydrochloride 2023-05-15 Valid Chemical 889
    31/10/2025 R L Fine Chem
    India
    		 R L FINE CHEM PVT. LTD. Bengaluru IN R0-CEP 2021-157 - Rev 00 Clomipramine Hydrochloride 2023-08-03 Valid Chemical 889